clinical trial · NCT04858425
Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
Covid19NiclosamidePlacebo
brief summary
This is a 2-part, 2-arm, Phase 2 , multicentre, randomized, double-blind, placebo-controlled study in adults with COVID-19 with gastrointestinal infection.
started
Apr 30, 2021
primary completion
Jun 4, 2022
completion
Sep 10, 2023
last updated
Oct 8, 2024
official title
A 2-Part, 2-Arm, Phase 2, Randomized, Double-Blind, Placebo-Controlled Study on the Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol